ClinicalTrials.Veeva

Menu

Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence

Intuitive Surgical logo

Intuitive Surgical

Status

Completed

Conditions

Pulmonary Nodule, Solitary
Lung Cancer

Treatments

Device: Ion Endoluminal System

Study type

Observational

Funder types

Industry

Identifiers

NCT04735341
ISI-IonLR-001

Details and patient eligibility

About

The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age of 18 years or older

    • Undergoing a lung biopsy procedure with Ion System
    • Have peripheral pulmonary lesion (5th bronchial generation or higher)
    • Willingness to participate as demonstrated by signing the informed consent

Exclusion criteria

  • Unable to provide informed consent

    • Presence of bilateral nodules intended to be biopsied during procedure
    • The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy
    • Vulnerable population (e.g., prisoners, mentally disabled)

Trial design

30 participants in 1 patient group

Subjects with planned Ion Endoluminal Procedure with pulmonary nodule
Treatment:
Device: Ion Endoluminal System

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems